Immunome, Inc. · NASDAQ:IMNM
Barchas Isaac sold 83,464 Immunome, Inc. shares (Form 4)
Traded Aug 10 to Aug 12, 2026 · Filed Aug 12, 2026
From Aug 10 to Aug 12, 2026, Barchas Isaac (Director) sold 83,464 Immunome, Inc. shares at an average US$26.35 for US$2.2M under a trading plan, leaving 92,211 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 83,464 shares
- Price
- US$26.35 average (US$26.07 to US$27.25)
- Value
- US$2.2M
- Holding after
- 92,211 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Sale | 10,125 | US$26.07 | 62,291 | Indirect |
| Aug 11, 2026 | Common Stock | Sale | 62,291 | US$26.23 | 0 | Indirect |
| Aug 12, 2026 | Common Stock | Sale | 11,048 | US$27.25 | 92,211 | Direct |
Source
Related
- Immunome, Inc.
- Barchas Isaac
- Immunome, Inc. shareholders
- Form 4 · Barchas Isaac · Aug 10, 2026
- Form 4 · Barchas Isaac · Jul 7, 2026
- Form 4 · Barchas Isaac · Jul 2, 2026
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Form 4 · Horn Kinney · Aug 6, 2026
- Form 4 · Horn Kinney · Jul 27, 2026